Elisabeth Harnden
Investment Executive
Development Capital
Elisabeth joined Downing in September 2023 as an Investment Analyst in the Development Capital team. She is responsible for deal execution and portfolio management. Prior to joining Downing, Elisabeth worked in the EY Healthcare and Life Sciences corporate finance team where she was involved in a variety of mid-market transactions.
She holds a BSc in Business Management from the University of Bath and is an ACA Chartered Accountant.
Investment Executive
Elisabeth joined Downing in September 2023 as an Investment Analyst in the Development Capital team. She is responsible for deal execution and portfolio management. Prior to joining Downing, Elisabeth worked in the EY Healthcare and Life Sciences corporate finance team where she was involved in a variety of mid-market transactions.
She holds a BSc in Business Management from the University of Bath and is an ACA Chartered Accountant.
Downing LLP does not provide advice or make personal recommendations and investors are strongly urged to seek independent advice before investing. Investments offered on this website carry a higher risk than many other types of investment and prospective investors should be aware that capital is at risk and the value of their investment may go down as well as up. Any investment should only be made on the basis of the relevant product literature and your attention is drawn to the risk, fees and taxation factors contained therein. Tax treatment depends on individual circumstances of each investor and may be subject to change in the future. Past performance is not a reliable indicator of future performance. Downing LLP is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 545025). Registered in England No. OC341575. Registered Office: Downing, 10 Lower Thames Street, London, EC3R 6EN.
VAT Number: 112 940 149
.jpg)
